Neurol. praxi. 2011;12(1):18-21

Tics and Tourette syndrome

MUDr.Ondřej Fiala
Neurologická klinika a Centrum klinických neurověd, 1. LF UK a VFN, Praha

Tics are one of the most common movement disorders. They are caused mainly by primary tic disorders in childhood, secondary tics

are rare. The most common cause of tics is transient tic disorder, which may affect up to 28% of schoolchildren. The most severe form

of tic disorder is Tourette‘s syndrome, which is characterized by multiple motor and vocal tics, and often accompanied by behavioral

problems. Education and lifestyle adjustment are the basis for the treatment of tics. Pharmacologic treatment is recommended only for

more severe forms of disease.

Keywords: tics, Tourette syndrome, treatment

Published: February 18, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fiala O. Tics and Tourette syndrome. Neurol. praxi. 2011;12(1):18-21.
Download citation

References

  1. Cavanna AE, Servo S, Monaco F, Robertson MM. The behavioral spectrum of Gilles de la Tourette syndrome. J Neuropsychiatry Clin Neurosci 2009; 21: 13-23. Go to original source... Go to PubMed...
  2. Fiala O, Růžička E. Mezinárodní databáze Touretteova syndromu - zapojení do projektu v České republice. Ces Slov Neurol Neurochir 2003; 66/99: 197-202.
  3. Fiala O, Růžička E. Touretteův syndrom - multilmediální CD-ROM. Praha: Cittadella 2007.
  4. Glaze DG, Frost JD, Jr., Jankovic J. Sleep in Gilles de la Tourette's syndrome: disorder of arousal. Neurology 1983; 33: 586-592. Go to original source... Go to PubMed...
  5. Cheung MY, Shahed J, Jankovic J. Malignant Tourette syndrome. Mov Disord 2007; 22: 1743-1750. Go to original source... Go to PubMed...
  6. Jankovic J, Růžička E. Tiky a Touretteův syndrom. Cas Lek Cesk 1997; 136: 399-404. Go to PubMed...
  7. Jankovic J, Gelineau-Kattner R, Davidson A. Tourette's syndrome in adults. Mov Disord 2010a; 25: 2171-2175. Go to original source... Go to PubMed...
  8. Jankovic J, Jimenez-Shahed J, Brown LW. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosurg Psychiatry 2010b; 81: 70-73. Go to original source... Go to PubMed...
  9. Kuhn J, Grundler TO, Lenartz D, Sturm V, Klosterkötter J, Huff W. Deep brain stimulation for psychiatric disorders. Dtsch Arztebl Int 2010; 107: 105-113. Go to original source... Go to PubMed...
  10. Kwak C, Dat Vuong K, Jankovic J. Premonitory sensory phenomenon in Tourette's syndrome. Mov Disord 2003; 18: 1530-1533. Go to original source... Go to PubMed...
  11. Murphy TK, Kurlan R, Leckman J. The immunobiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward. J Child Adolesc Psychopharmacol 2010; 20: 317-331. Go to original source... Go to PubMed...
  12. O'Rourke JA, Scharf JM, Yu D, Pauls DL. The genetics of Tourette syndrome: a review. J Psychosom Res 2009; 67: 533-545. Go to original source... Go to PubMed...
  13. Peterson BS, Leckman JF, Scahill L, Naftolin F, Keefe D, Charest NJ, Cohen DJ. Steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette's syndrome. Psychoneuroendocrinology 1992; 17: 553-563. Go to original source... Go to PubMed...
  14. Robertson MM. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. J Psychosom Res 2008; 65: 461-472. Go to original source... Go to PubMed...
  15. Swain JE, Scahill L, Lombroso PJ, King RA, Leckman JF. Tourette syndrome and tic disorders: a decade of progress. J Am Acad Child Adolesc Psychiatry 2007; 46: 947-968. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.